Clinical trial
Memantine Augmentation in Obsessive-Compulsive Disorder
NCT00264238 · Stanford University, Other · Completed
Key facts
| NCT number | NCT00264238 |
|---|---|
| Title | Memantine Augmentation in Obsessive-Compulsive Disorder |
| Official title | An Open-Label Trial of Memantine to Augment Response in the Treatment of Obsessive-Compulsive Disorder |
| Lead sponsor | Stanford University, Other |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Obsessive-Compulsive Disorder |
| Intervention type | Drug |
| Interventions | Memantine |
| Enrollment | 15 |
| Start date | Jan 1, 2006 |
| Primary completion | Jun 1, 2008 |
| Completion | Jun 1, 2008 |
| First posted | Dec 12, 2005 |
| Last update posted | May 30, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: